Want to see CHRS full AI Analyst Report?
Coherus Biosciences (CHRS) Ownership Overview
1.24% Insiders
10.24% Mutual Funds
8.69% Other Institutional Investors
8.45% ETFs
71.38% Public Companies and
Individual Investors
The ownership structure of Coherus Biosciences (CHRS) stock is a mix of institutional, retail, and individual investors. Approximately 27.39% of the company’s stock is owned by Institutional Investors, 1.24% is owned by Insiders, and 71.38% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $34128 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,300,361 | Institution | 4.08% | 7,308,419 | |
| 5,817,206 | Institution | 3.77% | 6,747,959 | |
| 4,992,887 | Institution | 3.23% | 5,791,749 | |
| 2,700,000 | Institution | 1.75% | 3,132,000 | |
| 1,607,367 | Institution | 1.04% | 1,864,546 | |
| 1,567,884 | Insider | 1.01% | 1,818,745 | |
| 1,509,314 | Institution | 0.98% | 1,750,804 | |
| 1,130,901 | Institution | 0.73% | 1,311,845 | |
| 791,361 | Institution | 0.51% | 917,979 | |
| 629,398 | Institution | 0.41% | 730,102 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,817,206 | Institution | 3.77% | 6,747,959 | |
| 2,700,000 | Institution | 1.75% | 3,132,000 | |
| 1,607,367 | Institution | 1.04% | 1,864,546 | |
| 1,509,314 | Institution | 0.98% | 1,750,804 | |
| 1,130,901 | Institution | 0.73% | 1,311,845 | |
| 629,398 | Institution | 0.41% | 730,102 | |
| 427,606 | Institution | 0.28% | 496,023 | |
| 391,000 | Institution | 0.25% | 453,560 | |
| 330,000 | Institution | 0.21% | 382,800 | |
| 269,176 | Institution | 0.17% | 312,244 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,953,617 | Institution | 2.56% | 4,783,877 | |
| 3,180,516 | Institution | 2.06% | 3,689,399 | |
| 1,512,438 | Institution | 0.98% | 1,830,050 | |
| 738,159 | Institution | 0.48% | 856,264 | |
| 707,068 | Institution | 0.46% | 855,552 | |
| 697,834 | Institution | 0.45% | 746,682 | |
| 442,919 | Institution | 0.29% | 513,786 | |
| 369,275 | Institution | 0.24% | 428,359 | |
| 205,070 | Institution | 0.13% | 219,425 | |
| 175,000 | Institution | 0.11% | 187,250 |
FAQ
Who Owns Coherus Biosciences (CHRS)?
According to the latest TipRanks data, approximately 8.69% of the company's stock is held by institutional investors, 1.24% is held by insiders, and 71.38% is held by retail investors.
What percentage of Coherus Biosciences (CHRS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 8.69% of Coherus Biosciences (CHRS) stock is held by institutional investors.
What percentage of Coherus Biosciences (CHRS) stock is held by retail investors?
According to the latest TipRanks data, approximately 71.38% of Coherus Biosciences (CHRS) stock is held by retail investors.
Who owns the most shares of Coherus Biosciences (CHRS)?
Vanguard owns the most shares of Coherus Biosciences (CHRS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.